NDC 50090-1849
RECOMBIVAX HB
Hepatitis B Vaccine (recombinant)
RECOMBIVAX HB is a Intramuscular; Subcutaneous Injection, Suspension in the Vaccine category. It is labeled and distributed by A-s Medication Solutions. The primary component is Hepatitis B Virus Subtype Adw Hbsag Surface Protein Antigen.
| Product ID | 50090-1849_017b63a7-86ba-419f-ae04-a1f576f5edb9 |
| NDC | 50090-1849 |
| Product Type | Vaccine |
| Proprietary Name | RECOMBIVAX HB |
| Generic Name | Hepatitis B Vaccine (recombinant) |
| Dosage Form | Injection, Suspension |
| Route of Administration | INTRAMUSCULAR; SUBCUTANEOUS |
| Marketing Start Date | 1986-07-23 |
| Marketing Category | BLA / BLA |
| Application Number | BLA101066 |
| Labeler Name | A-S Medication Solutions |
| Substance Name | HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN |
| Active Ingredient Strength | 10 ug/mL |
| Pharm Classes | Inactivated Hepatitis B Virus Vaccine [EPC],Actively Acquired Immunity [PE],Hepatitis B Vaccines [CS],Vaccines, Inactivated [CS] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 50090-1849-0
1 VIAL, SINGLE-DOSE in 1 POUCH (50090-1849-0) > 1 mL in 1 VIAL, SINGLE-DOSE
| Marketing Start Date | 1986-07-23 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 50090-1849-0 [50090184900]
RECOMBIVAX HB INJECTION, SUSPENSION
| Marketing Category | BLA |
| Application Number | BLA101066 |
| Product Type | VACCINE |
| Marketing Start Date | 1986-07-23 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| HEPATITIS B VIRUS SUBTYPE ADW HBSAG SURFACE PROTEIN ANTIGEN | 10 ug/mL |
Pharmacological Class
- Inactivated Hepatitis B Virus Vaccine [EPC]
- Actively Acquired Immunity [PE]
- Hepatitis B Vaccines [CS]
- Vaccines
- Inactivated [CS]
NDC Crossover Matching brand name "RECOMBIVAX HB" or generic name "Hepatitis B Vaccine (recombinant)"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-4093 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4094 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4981 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4992 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 0006-4995 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1716 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1719 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1849 | RECOMBIVAX HB | Hepatitis B Vaccine (Recombinant) |
| 50090-1223 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
| 50090-1706 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
| 58160-820 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
| 58160-821 | ENGERIX-B | Hepatitis B Vaccine (Recombinant) |
Trademark Results [RECOMBIVAX HB]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 RECOMBIVAX HB 73509689 1338762 Live/Registered |
Merck & Co., Inc. 1984-11-19 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.